1. Home
  2. HUMAW vs EVLVW Comparison

HUMAW vs EVLVW Comparison

Compare HUMAW & EVLVW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUMAW
  • EVLVW
  • Stock Information
  • Founded
  • HUMAW 2004
  • EVLVW 2013
  • Country
  • HUMAW United States
  • EVLVW United States
  • Employees
  • HUMAW 220
  • EVLVW 287
  • Industry
  • HUMAW Biotechnology: Pharmaceutical Preparations
  • EVLVW Computer peripheral equipment
  • Sector
  • HUMAW Health Care
  • EVLVW Technology
  • Exchange
  • HUMAW Nasdaq
  • EVLVW Nasdaq
  • Market Cap
  • HUMAW N/A
  • EVLVW N/A
  • IPO Year
  • HUMAW N/A
  • EVLVW N/A
  • Fundamental
  • Price
  • HUMAW $0.19
  • EVLVW $0.76
  • Analyst Decision
  • HUMAW
  • EVLVW
  • Analyst Count
  • HUMAW 0
  • EVLVW 0
  • Target Price
  • HUMAW N/A
  • EVLVW N/A
  • AVG Volume (30 Days)
  • HUMAW 14.2K
  • EVLVW 17.7K
  • Earning Date
  • HUMAW 03-21-2025
  • EVLVW 02-28-2025
  • Dividend Yield
  • HUMAW N/A
  • EVLVW N/A
  • EPS Growth
  • HUMAW N/A
  • EVLVW N/A
  • EPS
  • HUMAW N/A
  • EVLVW N/A
  • Revenue
  • HUMAW N/A
  • EVLVW $89,220,000.00
  • Revenue This Year
  • HUMAW N/A
  • EVLVW N/A
  • Revenue Next Year
  • HUMAW N/A
  • EVLVW N/A
  • P/E Ratio
  • HUMAW N/A
  • EVLVW N/A
  • Revenue Growth
  • HUMAW N/A
  • EVLVW 17.67
  • 52 Week Low
  • HUMAW $1.18
  • EVLVW $0.28
  • 52 Week High
  • HUMAW $1.34
  • EVLVW $0.34
  • Technical
  • Relative Strength Index (RSI)
  • HUMAW N/A
  • EVLVW N/A
  • Support Level
  • HUMAW N/A
  • EVLVW N/A
  • Resistance Level
  • HUMAW N/A
  • EVLVW N/A
  • Average True Range (ATR)
  • HUMAW 0.00
  • EVLVW 0.00
  • MACD
  • HUMAW 0.00
  • EVLVW 0.00
  • Stochastic Oscillator
  • HUMAW 0.00
  • EVLVW 0.00

About HUMAW Humacyte Inc. Warrant

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

About EVLVW Evolv Technologies Holdings Inc.

Evolv Technologies Holdings Inc offers an AI-based touchless security screening. Its touchless security screening systems use artificial intelligence software, cloud services, and sensors to reliably detect dangerous weapons while ignoring harmless items like cell phones, laptops, and keys. It offers products for purchase under a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue, and creates expansion and upsell opportunities. The firm operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.

Share on Social Networks: